Clinical aspects of the management of patients with psoriasis: can we do better?

Cite item

Full Text

Review of N.S. Rudneva speech

##article.viewOnOriginalSite##

Raychaudhuri SP. Clin Rev Allergy Immunol. 2013; 44: 183-93.
Miossec P, Kolls JK. Nat Rew Drug Discov 2012; 11: 763-76.
Smith JA et al. Arthritis Rheumatol 2014; 66: 231-41.
Palmer MT. Nature 2007; 448: 416-8.
Suzuki E et al. Autoimmun Rev 2014; 13: 496-502.
Lubberts E et al. Nat Rev Rheumatol 2015; 11: 415-29.
Papp et al. J Invest Dermatol 2012; 132: 2466-9.
Guettner A et al. Methods for treating psoriasis using IL-17 antagonists. WIPO patent 2012045848 A1. 12 April 2012. http://www.google.nl/patents/WO2012045848A17chru
Blauvelt A et al. Br J Dermatol 2019. doi: 10.1111/bjd.18851
Papp KA et al. Br J Dermatol 2018; 178: 674-81.
Reich K et al. Br J Dermatol 2017; 177: 1014-23.
Mease PJ et al. Ann Rheum Dis 2020; 79: 123-31.
Blauvelt A et al. Br J Dermatol 2019. doi: 10.1111/bjd.18851
Loos AM et al. J Am Acad Dermatol 2018; 79: 135-44.e7.
Armstrong AW et al. Постер представлен на: AAD 2019.
Gordon KB, Blauvelt A, Papp KA et al. N Engl J Med 2016; 375: 345-56.
Griffiths CE et al. Lancet 2016; 386: 541-51.
Georgakopoulos JR et al. J Am Acad Dermatol 2018; 79: 155-7.
Gasslitter I et al. Arch Dermatol Res 2019; 311: 421-4.
Sherman S et al. Acta Derm Venereol 2019; 99: 769-73.
Bokor-Billmann T et al. J Dermatolog Treat 2019; 30: 216-20.
Conti A et al. Br J Dermatol 2019; 180: 1547-8.